Oman

Healthcare & Pharmaceutical Market Intelligence

The GCC’s Sustainable Healthcare Growth MarketVision Oman 2040Import-Dependent Pharma

Oman represents one of the GCC’s fastest developing healthcare markets, expanding healthcare infrastructure, growing private-sector participation, and sustained government investment.

Healthcare network map of Oman

5.3M

Population

USD 423M

Pharma Imports

USD 303M

Pharma Market

USD 5.1B

Healthcare Market

15–20%

Couple Infertility

1. Healthcare Expansion

Sustainable Investment

  • ✓Vision Oman 2040
  • ✓Continuous healthcare infrastructure expansion
  • ✓Increasing government investment
  • ✓Growing private-sector participation
  • ✓Steady healthcare modernization
Healthcare network map of GCC

2. Pharmaceutical Intelligence

Key Market Indicators

USD 303M

Estimated Market Size (2024)

USD 474M

Growth Outlook by 2031

USD 28.25M

Dietary Supplements (2024)

USD 42.45M

Supplements Forecast (2030) • 6.98% CAGR

Oman pharmaceutical distribution network

3. Pharmaceutical Trade Intelligence

USD 423M Imports • Net −USD 347M

Top Import Sources

  • Switzerland — USD 89.5M
  • Germany — USD 57.3M
  • India — USD 52.5M
  • United States — USD 39.4M
  • Saudi Arabia — USD 34.3M

Supplement Categories

  • Preventive Healthcare
  • Wellness Lifestyle
  • Healthy Aging
  • Sports Nutrition
  • Personalized Nutrition
GCC pharmaceutical trade network

4. Reproductive Health Intelligence

Oman Study • 259 Omani Couples

53.7%

Female factor infertility (≈5 out of 10 cases)

41.7%

Male factor infertility (≈4 out of 10 cases)

14.3%

Combined male & female factors

21.6%

PCOS among infertile women (tertiary referral study)

4.6–7%

PCOS among women of reproductive age

Sources: Oman Study of 259 Omani couples (unexplained infertility 4.6%) • Omani tertiary referral study • Selected Omani cohorts

5. Growing Demand

Reproductive & Preventive Health

Fertility support

Pre-conception care

Reproductive wellness

Preventive healthcare awareness

Sustained dependence on imported pharmaceuticals

6. Why Oman Matters

One of the GCC’s most promising long-term healthcare markets

Growing private-sector participation

USD 423M in pharmaceutical imports (2024)

Expanding fertility support demand

Strategically important growth market within the GCC

Partnerships

Partner With Us

Connect with NEWPASSIVE to explore healthcare, distribution, institutional, and business partnership opportunities.

Contact Information
Your Request